Keyphrases
Ascites
86%
Hepatocellular Carcinoma
82%
Yttrium-90 Radioembolization
58%
Radioembolization
49%
Liver Transplantation
46%
Transjugular Intrahepatic Portosystemic Shunt
38%
Cirrhosis
37%
MELD Score
37%
Chronic Liver Disease
36%
Ascitic Fluid
34%
Cirrhotic Patients
32%
Large Volume
31%
Serum Creatinine
31%
Chronic Kidney Disease
28%
Creatinine
28%
Bilirubin
28%
Median Overall Survival
27%
Renal Disease
26%
Overall Survival
26%
Chronic Hepatitis C Virus Infection
23%
High Dose
23%
Vaccination
23%
Cirrhotic Ascites
23%
T1-T2
23%
Albumin
23%
Non-responders
23%
Infection Treatment
23%
Hepatitis B Vaccine
23%
Pathophysiology
23%
Aneurysm Embolization
23%
Hepatitis C Virus
23%
Inflammatory State
23%
Yttrium-90
23%
Portal Hypertension
23%
Patient Cohort
23%
Albumin-bilirubin Grade
23%
Procalcitonin
23%
Score Analysis
23%
Consensus Interferon
23%
Pegylated Interferon Plus Ribavirin
23%
Lung Shunt
23%
Lung Shunt Fraction
23%
Partial Responder
23%
Peritoneal Drainage
23%
Hepatic Disease
23%
Adverse Events
23%
Arterial Aneurysm
23%
Prognostic Role
23%
Multidisciplinary Tumor Board
23%
Patient Analysis
23%
Medicine and Dentistry
Radioembolization
100%
Hepatocellular Carcinoma
95%
Ascites
82%
Yttrium 90
71%
Overall Survival
54%
Liver Transplantation
48%
Liver Cirrhosis
46%
Chronic Liver Disease
36%
Transjugular Intrahepatic Portosystemic Shunt
35%
Model For End Stage Liver Disease Score
33%
Bilirubin
28%
Albumin
27%
Adverse Event
27%
Hepatitis C Virus
25%
Portal Hypertension
23%
Hepatitis B Virus
23%
Umbilical Hernia
23%
Embolization
23%
Neoplasm
23%
Abdominal Drainage
23%
Drug Megadose
23%
Shunt Creation
23%
Virus Vaccine
23%
Aneurysm
23%
Pathophysiology
23%
Ribavirin
23%
Infectious Disease Treatment
23%
Chronic Hepatitis C
23%
Cytokine
23%
Procalcitonin
23%
Peginterferon
23%
Consensus Interferon
23%
Side Effect
23%
Pulmonary Shunt
23%
Diseases
20%
Paracentesis
18%
Hazard Ratio
16%
Creatinine
14%
Hepatitis C
13%
Proteinase Inhibitor
12%
Decompensated Liver Cirrhosis
11%
Infection
11%
Recurrence Free Survival
10%
Liver Graft
10%
Polymerase
9%
Cell Count
9%
Liver Disease
9%
Immune Response
9%
Spontaneous Bacterial Peritonitis
9%
Arm
8%